In the future, perhaps any and all new indications for drugs will be discovered and brought forth before approval. Moving in this direction is a new project involving Pfizer and Caliper, which will perform in-vivo tests evaluating new indications for drugs in Pfizer's pipeline. For more, here is the press release.